Similar Items: CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept, Diagnosis, and Clinical Trial Design
- Interchangeability of CSF and PET to identify Alzheimer's disease pathology
- Perceptions of the use of biomarkers for Alzheimer's disease diagnosis: A systematic review and synthesis of the qualitative literature
- Blood DNA methylation signature of cognitive reserve moderates the association between CSF tau pathology and memory in prodromal Alzheimer's disease
- A fovea‐centered retinal signature linked to plasma biomarkers in prodromal Alzheimer's disease
- Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatment
- Physical activity attenuates the association between allostatic load and early Alzheimer's disease‐related biomarkers in older adults